Literature DB >> 12544988

Prognostic value of surfactant proteins A and D in patients with acute lung injury.

Ivan W Cheng1, Lorraine B Ware, Kelly E Greene, Thomas J Nuckton, Mark D Eisner, Michael A Matthay.   

Abstract

OBJECTIVE: The primary objective of this study was to test the hypothesis that in patients intubated for acute lung injury, lower concentrations of surfactant proteins A and D in the pulmonary edema fluid and higher concentrations in the plasma are associated with more severe lung injury and worse clinical outcomes.
DESIGN: Observational study.
SETTING: Intensive care unit patients in a tertiary university hospital and a university-affiliated city hospital. PATIENTS: Thirty-eight intubated, mechanically ventilated intensive care unit patients with acute lung injury or acute respiratory distress syndrome as defined by the North American European Consensus Conference.
INTERVENTIONS: Undiluted pulmonary edema fluid and plasma samples were collected within 24 hrs of endotracheal intubation in all patients.
MEASUREMENTS AND MAIN RESULTS: The concentrations of surfactant proteins A and D were measured in pulmonary edema fluid and in plasma. Plasma surfactant protein A, but not surfactant protein D, was higher in patients with fewer days of unassisted ventilation (p = .03) and in patients with an absence of intact alveolar fluid clearance (p =.03). In contrast, pulmonary edema fluid surfactant protein D, but not surfactant protein A, was lower in patients with worse oxygenation, as measured by the alveolar-arterial oxygen difference (p = .01) and was lower in the patients who died (2646 ng/mL) compared with those who survived (5503 ng/mL; p = .02).
CONCLUSIONS: These results demonstrate that reduced pulmonary edema fluid surfactant protein D and elevated plasma surfactant protein A concentrations at the onset of acute lung injury may be associated with more severe disease and worse clinical outcome and may serve as valuable biochemical markers of prognosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12544988     DOI: 10.1097/00003246-200301000-00003

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  45 in total

1.  Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS.

Authors:  U Hamid; A Krasnodembskaya; M Fitzgerald; M Shyamsundar; A Kissenpfennig; C Scott; E Lefrancais; M R Looney; R Verghis; J Scott; A J Simpson; J McNamee; D F McAuley; C M O'Kane
Journal:  Thorax       Date:  2017-01-12       Impact factor: 9.139

2.  Searching for the Holy Grail of the acute respiratory distress syndrome.

Authors:  Marc Moss
Journal:  Intensive Care Med       Date:  2006-06-23       Impact factor: 17.440

3.  Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome.

Authors:  Olivier Lesur; Stephan Langevin; Yves Berthiaume; Martin Légaré; Yoanna Skrobik; Jean-François Bellemare; Bruno Lévy; Yvan Fortier; Francois Lauzier; Gina Bravo; Marc Nickmilder; Eric Rousseau; Alfred Bernard
Journal:  Intensive Care Med       Date:  2006-06-23       Impact factor: 17.440

4.  Anti-inflammatory and antioxidant effects of infliximab on acute lung injury in a rat model of intestinal ischemia/reperfusion.

Authors:  Ahmet Guzel; Mehmet Kanter; Aygul Guzel; Ahmet Pergel; Mustafa Erboga
Journal:  J Mol Histol       Date:  2012-03-03       Impact factor: 2.611

5.  Donor smoking is associated with pulmonary edema, inflammation and epithelial dysfunction in ex vivo human donor lungs.

Authors:  L B Ware; J W Lee; N Wickersham; J Nguyen; M A Matthay; C S Calfee
Journal:  Am J Transplant       Date:  2014-08-21       Impact factor: 8.086

6.  N-Acetylcysteine counteracts oxidative stress and protects alveolar epithelial cells from lung contusion-induced apoptosis in rats with blunt chest trauma.

Authors:  Yeter Topcu-Tarladacalisir; Taner Tarladacalisir; Melike Sapmaz-Metin; Altemur Karamustafaoglu; Yesim Hulya Uz; Meryem Akpolat; Aysegul Cerkezkayabekir; Fatma Nesrin Turan
Journal:  J Mol Histol       Date:  2014-01-18       Impact factor: 2.611

Review 7.  Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise.

Authors:  M Isabel García-Laorden; José A Lorente; Carlos Flores; Arthur S Slutsky; Jesús Villar
Journal:  Ann Transl Med       Date:  2017-07

8.  Discovery of the gene signature for acute lung injury in patients with sepsis.

Authors:  Judie A Howrylak; Tamas Dolinay; Lorrie Lucht; Zhaoxi Wang; David C Christiani; Jigme M Sethi; Eric P Xing; Michael P Donahoe; Augustine M K Choi
Journal:  Physiol Genomics       Date:  2009-01-27       Impact factor: 3.107

9.  Restoration of lung surfactant protein D by IL-6 protects against secondary pneumonia following hemorrhagic shock.

Authors:  Stephen Thacker; Ana Moran; Mihalis Lionakis; Mary-Ann A Mastrangelo; Tripti Halder; Maria del Pilar Huby; Yong Wu; David J Tweardy
Journal:  J Infect       Date:  2013-11-27       Impact factor: 6.072

Review 10.  Bench-to-bedside review: Inhaled nitric oxide therapy in adults.

Authors:  Benedict C Creagh-Brown; Mark J D Griffiths; Timothy W Evans
Journal:  Crit Care       Date:  2009-05-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.